Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues

British Journal of Pharmacology

Volumn 127, Issue 5, 1999, Pages 1256-1262

  Cox, S L ^a   Trendelenburg, A U ^a   Starke, K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiotensin; Angiotensin receptors; Mouse atria; Mouse hippocampus; Mouse hypothalamus; Mouse occipito parietal cortex; Mouse spleen; Noradrenaline release

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; NORADRENALIN; SARALASIN;

ANIMAL TISSUE; ARTICLE; HEART ATRIUM; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; SPLEEN;

ANGIOTENSIN II; ANGIOTENSIN III; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; MALE; MICE; NOREPINEPHRINE; RECEPTORS, ANGIOTENSIN; SPLEEN;

EID: 0032772714     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702652     Document Type: Article

References (40)

1. BOICOS, K.M., COX, S.L. & STORY, D.F. (1998). Modulation of noradrenergic transmission in rat isolated trachea by angiotensin I and angiotensin II. Naunyn-Schmiedeberg's Arch. Pharmacol., 358 (supp 1): R293.
2. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension, 26, 752-757.
3. BRASCH, H., SIEROSLAWSKI, L. & DOMINIAK, P. (1993). Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension, 22, 699-704.
4. CHIU, A.T., HERBLIN, W.F., MCCALL, D.E., ARDECKY, R.J., CARINI, D.J., DUNCIA, J.V., PEASE, L.J., WONG, P.C., WEXLER, R.R., JOHNSON, A.L. & TIMMERMANS, P.B.M.W.M. (1989). Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Comm., 165, 196-203.
5. COX, S.L., BEN, A., STORY, D.F. & ZIOGAS, J. (1995). Evidence for the involvement of different receptor subtypes in the pre-and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br. J. Pharmacol., 114, 1057-1063.
6. COX, S.L., STORY, D.F. & ZIOGAS, J. (1996a). Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat. Br. J. Pharmacol., 119, 965-975.
7. COX, S.L., STORY, D.F. & ZIOGAS, J. (1996b). Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat. Br. J. Pharmacol., 119, 976-984.
8. DE GASPARO, M., CATT, K.J. & INAGAMI, T. (1998). Angiotensin receptors. In The IUPHAR Compendium of Receptor Characterization and Classification, ed. Girdlestone, D. pp 80-86. Cambridge: London: IUPHAR Media.
9. GANTEN, D., LANG, R.E., LEHMANN, E. & UNGER, T. (1984). Brain angiotensin: on the way to becoming a well-studied neuropeptide system. Biochem. Pharmacol., 33, 3523-3528.
10. 3H-noradrenaline from the rabbit hypothalamus. Eur. J. Pharmacol., 56, 173-176.
11. 3H] norepinephrine from rat atria. Hypertension, 24, 457-460.
12. 3H]dopa in various regions of the brain. J. Neurochem., 13, 655-669.
13. GUIMARAES, S., PAIVA, M.Q. & MOURA, D. (1998). Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries. Br. J. Pharmacol., 124, 1207-1212.
14. HERTTING, G. & SCHIEFTHALER, T. (1963). Beziehung zwischen Durchflussgrösse and Noradrenalinfreisetzung bei Nervenreizung der isolierten durchströmten Katzenmilz. Naunyn-Schmiedebergs Arch. exp. Pathol. Pharmakol., 246, 13-14.
15. 3H]-noradrenaline release following postganglionic sympathetic nerve stimulation in the isolated cat spleen. Br. J. Pharmacol., 26, 686-696.
16. 3H]noradrenaline release and phosphatidylinositol hydrolysis in the parietal cortex and locus coeruleus of the rat. J. Neurochem., 49, 1541-1549.
17. JACKSON, E.K. & GARRISON, J.C. (1996). Renin and angiotensin. In The Pharmacological Basis of Therapeutics, Ed. 9, ed. Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. & Goodman Gilman, A. pp 733-758. New York: McGraw-Hill.
18. LI, Q., FEENSTRA, M., PFAFFENDORF, M., EIJSMAN, L. & VAN ZWIETEN, P.A. (1997). Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. J. Cardiovasc. Pharmacol., 29, 451-456.
19. LI, Q., ZHANG, J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1995). Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br. J. Pharmacol., 116, 2963-2970.
20. LI, Q., ZHANG, J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1996). Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria. Br. J. Pharmacol., 118, 1653-1658.
21. 3H-norepinephrine release in central tissue of spontaneously hypertensive rats but not in Wistar-Kyoto rats: effects of sodium depletion. J. Cardiovasc. Pharmacol., 8, 582-587.
22. MELDRUM, M.J., XUE, C.-S., BADINO, L. & WESTFALL, T.C. (1984). Angiotensin facilitation of noradrenergic neurotransmission in central tissues of the rat: Effects of sodium restriction. J. Cardiovasc. Pharmacol., 6, 989-995.
23. MOLDERINGS, G.J., LIKUNGU, J., HENTRICH, F. & GÖTHERT, M. (1988). Facilitatory prejunctional angiotensin receptors on the sympathetic nerves of the human saphenous vein and pulmonary artery. Potential involvement in β-adrenoceptor-mediated facilitation of noradrenaline release. Naunyn-Schmiedeberg's Arch. Pharmacol., 338, 228-233.
24. MOORE, A.F., HALL, M.H. & KHAIRALLAH, P.A. (1976). A comparison of the effects of angiotensin II and heptapeptide on smooth muscle (vascular and uterine). Eur. J. Pharmacol., 39, 101-107.
25. MOURA, D., VAZ-DA-SILVA, M., MAGINA, S., PINHEIRO, H. & GUIMARAES, S. (1997). Involvement of angiotensin II receptors in the facilitatory effect of bradykinin on noradrenaline release from the rat left ventricle. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, R51.
26. MUSGRAVE, I.F. & MAJEWSKI, H. (1989). Effect of phorbol ester and pertussis toxin on the enhancement of noradrenaline release by angiotensin II in mouse atria. Br. J. Pharmacol., 96, 609-616.
27. OHIA, S.E. & JUMBLATT, J.E. (1993). Prejunctional receptors and second messengers for angiotensin II in the rabbit iris-ciliary body. Exp. Eye Res., 57, 419-425.
28. PEACH, M.J. (1977). Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev., 57, 313-370.
29. PENDLETON, R.G., GESSNER, G. & HORNER, E. (1991). Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues. J. Pharmacol. Exp. Ther., 256, 614-620.
30. RAJANAYAGAM, M.A.S., MUSGRAVE, I.F., RAND, M.J. & MAJEWSKI, H. (1989). Facilitation of noradrenaline release by isoprenaline is not mediated by angiotensin II in mouse atria and rat tail artery. Arch. Int. Pharmacodyn., 299, 185-199.
31. RUMP, L.C., BOHMANN, C., SCHAIBLE, U., SCHULTZE-SEEMAN, W. & SCHOLLMEYER, P.J. (1995). β-adrenergic, angiotensin II, and bradykinin receptors enhance neurotransmission in human kidney. Hypertension, 26, 445-451.
32. 2-adrenoceptor-but not facilitatory angiotensin II receptor-mediated modulation of noradrenaline release from rat hypothalamic slices. Jap. J. Pharmacol., 62, 119-122.
33. STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol., 77, 1-124.
34. STORGAARD, T. & NEDERGAARD, O.A. (1997). Prejunctional modulation by angiotensins of noradrenaline release from sympathetic neurons in isolated rabbit aorta. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 706-711.
35. SUZUKI, Y., MATSUMURA, Y., EGI, Y. & MORIMOTO, S. (1992). Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis by stimulation of renal nerves in anesthetized dogs. J. Pharmacol. Exp. Ther., 263, 956-963.
36. TAUBE, H.D., STARKE, K. & BOROWSKI, E. (1977). Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 299, 123-141.
37. TRACHTE, G.J. (1988). Angiotensin effects on vas deferens adrenergic and purinergic neurotransmission. Eur. J. Pharmacol., 146, 261-269.
38. WONG, P.C., HART, S.D. & TIMMERMANS, P.B.M.W.M. (1991). Effect of angiotensin II antagonism on canine renal sympathetic nerve function. Hypertension, 17, 1127-1134.
39. ZHANG, J., PHAFFENDORF, M., ZHANG, J.S. & VAN ZWIETEN, P.A. (1994). A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations. Eur. J. Pharmacol., 252, 337-340.
40. ZIMMERMAN, B.G., GOMER, S.K. & LIAO, J.C. (1972). Action of angiotensin on vascular adrenergic nerve endings: Facilitation of norepinephrine release. Fed. Proc., 31, 1344-1350.